1 / 19

Lecture 12. Stem Cells, Nuclear Transplantation, and Combined Cell & Gene Therapy Strategies

Lecture 12. Stem Cells, Nuclear Transplantation, and Combined Cell & Gene Therapy Strategies. Gene Defects Can be Corrected By Homologous Recombination. Embryonic Stem (ES) Cells are Derived from the Inner Cell Mass of the Blastocyst ES cells are Totipotent in vivo.

conley
Download Presentation

Lecture 12. Stem Cells, Nuclear Transplantation, and Combined Cell & Gene Therapy Strategies

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Lecture 12. Stem Cells, Nuclear Transplantation, and Combined Cell & Gene Therapy Strategies

  2. Gene Defects Can be Corrected By Homologous Recombination

  3. Embryonic Stem (ES) Cells are Derived from the Inner Cell Mass of the Blastocyst ES cells are Totipotent in vivo Totipotent=can become ALL Cell Types (Including Germ Cells)

  4. Adult Stem Cells can be Derived from Most Tissues: These Cells are Pluripotent Pluripotent=Can reconstitute some, but not all, cell types

  5. ES Cells can be Induced to Differentiate into Pluripotent Stem Cells in vitro, given appropriate genetic or hormonal stimuli

  6. Step 3B: Differentiate ES cells to HSC in vitro And Place these cells in Rag2-/- Mice Step 1: Create ES cells by Transplanting the Nucleus of a Rag2 -/- mouse Step 2: Repair the Rag2 gene in the ES Cells Strategy for Today’s Paper: Step 3A: Test for Rescue Using Mice Created from the ES Cells

  7. Step 1A:

  8. Step 1B:

  9. Step 1C: Let Embryo with Nuclear Transplant Develop To the Blastocyst Stage and Create ntES cell lines

  10. Southern Blotshowing the Repair Step 2: Strategy for Repairing the Mutant Rag2 Allele after Nuclear Transplantation

  11. T-cell Receptor Chains are Rearranged in the Rag R/- Mice Step 3A: Mice Are Made From Repaired ntES Cells

  12. Step 3A: Mice Are Made From Repaired ntES Cells Complete Immune System is Reconstituted in these Mice

  13. Step 3A: Mice Are Made From Repaired ntES Cells Complete Immune System is Reconstituted when Bone Marrow from these Mice is Transferred into Rag2 -/- Mice

  14. Step 3B: Reconstitute Mice with Pluripotent Stem Cells Derived from the Repaired ntES cells Infect with HoxB4 Retrovirus Vector

  15. Step 3B: First Attempts Were Unsuccessful: No Rescue of Immune System Observed • Hypothesis: The ntES Derived-Stem Cells Do Not Express • Correct Levels of Histocompatibility Type I Antigens • and are Eliminated by Natural Killer (NK) cells. • Use anti-NK antibody to remove NK cells in Rag-/- Mice • Use double KO mice: Rag2 -/- and • IL-2 Common Cytokine Receptor g Chain (gC) -/- • As Recipients

  16. Results: Complete Rescue Of Myeloid Lineages, but only low level rescue of B-cellsandT-Cells Modest rescue of B-cells but not of T-cells The Repaired Allele Is present in the Mice

  17. Rearranged T-cell receptors are detected by PCR Analysis of the ntES Engrafted Mice (~20% of WT)

  18. ntES Engrafted Mice Produce Antibodies

  19. Conclusion: Need to be able to make better Hematopoietic Stem Cells from the ntES cells Simply overexpressing Hox4B with the Retrovirus Vector Favors Myeloid vs. Lymphoid Differentiation Retrovirus Gene Transfer is ineffective for Gene Therapy.

More Related